Concepedia

James Sanderson

JS

Statistics

Publications

10

Citations

617

H-Index

10

Active since

1988

Affiliations

IDEX Corporation (United States)(Current)

Harrison Medical Center

James Sanderson is an author at IDEX Corporation (United States) specializing in antibody engineering, pharmacy, and protein engineering.

Publications per year

1988–2004

10

Publications

10

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

Alan R. Fritzberg, Paul G. Abrams, Paul L. Beaumier et al. · Proceedings of the National Academy of Sciences · 1988 · 161 citations · Full text

, , +17

A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.

Jody Schultz, Yukang Lin, James Sanderson et al. · PubMed · 2000 · 127 citations

, , +17

Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.

S. Kasina, T. Nageswara Rao, A. Srinivasan et al. · PubMed · 1991 · 70 citations

, , +17

Reduced antibody response to streptavidin through site‐directed mutagenesis

Damon L. Meyer, Jody Schultz, Yukang Lin et al. · Protein Science · 2001 · 70 citations · Full text

, , +17

Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

Nai‐Kong V. Cheung, Shakeel Modak, Yukang Lin et al. · PubMed · 2004 · 56 citations

, , +13

1–5 of 10